Ingredion (NYSE:INGR) Stock Rating Upgraded by Wall Street Zen

Ingredion (NYSE:INGR) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.

Several other equities analysts also recently weighed in on the company. Weiss Ratings restated a “hold (c)” rating on shares of Ingredion in a report on Monday. UBS Group decreased their target price on shares of Ingredion from $130.00 to $119.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. BMO Capital Markets cut their price target on shares of Ingredion from $143.00 to $123.00 and set a “market perform” rating on the stock in a report on Wednesday, November 5th. Barclays restated an “equal weight” rating and issued a $124.00 price objective (down from $168.00) on shares of Ingredion in a report on Thursday, November 6th. Finally, Zacks Research raised Ingredion from a “strong sell” rating to a “hold” rating in a research report on Monday, December 22nd. One investment analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $124.33.

Ingredion Price Performance

INGR stock opened at $109.74 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.79 and a current ratio of 2.75. The firm has a 50 day moving average price of $109.80 and a 200-day moving average price of $121.81. Ingredion has a 52-week low of $102.31 and a 52-week high of $141.78. The firm has a market capitalization of $6.97 billion, a price-to-earnings ratio of 10.94, a PEG ratio of 0.88 and a beta of 0.72.

Ingredion (NYSE:INGR) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $2.75 earnings per share for the quarter, topping the consensus estimate of $2.73 by $0.02. The company had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.90 billion. Ingredion had a return on equity of 18.14% and a net margin of 9.07%.Ingredion has set its FY 2025 guidance at 11.100-11.300 EPS. Equities research analysts forecast that Ingredion will post 11.14 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of INGR. AQR Capital Management LLC grew its stake in shares of Ingredion by 143.1% during the 3rd quarter. AQR Capital Management LLC now owns 1,191,118 shares of the company’s stock valued at $144,685,000 after purchasing an additional 701,063 shares during the period. Norges Bank bought a new stake in Ingredion during the second quarter valued at approximately $82,779,000. Millennium Management LLC increased its holdings in Ingredion by 1,093.5% during the first quarter. Millennium Management LLC now owns 365,693 shares of the company’s stock valued at $49,445,000 after buying an additional 335,052 shares during the last quarter. Nordea Investment Management AB raised its position in Ingredion by 66.3% in the second quarter. Nordea Investment Management AB now owns 722,933 shares of the company’s stock worth $97,531,000 after acquiring an additional 288,201 shares during the period. Finally, Snyder Capital Management L P boosted its stake in shares of Ingredion by 22.0% during the 3rd quarter. Snyder Capital Management L P now owns 1,323,847 shares of the company’s stock worth $161,655,000 after acquiring an additional 238,420 shares during the last quarter. Institutional investors own 85.27% of the company’s stock.

About Ingredion

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.